Sildenafil is one of the most widely used treatments for erectile dysfunction (ED) in the UK, but many men wonder whether it increases timing — that is, how long it takes to work, how long its effects last, and whether it extends sexual performance. Understanding sildenafil's timing is essential for using it safely and effectively. This article explains how sildenafil works, when to take it, how long its effects last, and what factors influence its performance, drawing on NHS, NICE, BNF, and MHRA guidance.

What Is Sildenafil and How Does It Work?

Sildenafil is a medicine commonly used to treat erectile dysfunction (ED) in men. It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors. Originally developed to treat cardiovascular conditions, sildenafil was subsequently found to be effective for ED and is now a well-established treatment for this condition in the UK. It is available under the brand name Viagra, as well as generic formulations approved by the Medicines and Healthcare products Regulatory Agency (MHRA).

In the UK, most sildenafil products are prescription-only medicines (POM). However, Viagra Connect 50 mg has been reclassified as a Pharmacy (P) medicine, meaning it can be obtained from a registered pharmacist without a prescription, following an appropriate assessment, for men aged 18 and over. Other strengths and formulations remain prescription-only. This reclassification was approved by the MHRA following a public assessment process.

The mechanism of action centres on improving blood flow to the penis during sexual stimulation. When a man becomes sexually aroused, the body releases nitric oxide in the erectile tissue of the penis. This triggers an enzyme called guanylate cyclase, which increases levels of cyclic guanosine monophosphate (cGMP). The cGMP relaxes smooth muscle cells in the blood vessels of the penis, allowing increased blood flow and facilitating an erection. However, another enzyme — PDE5 — breaks down cGMP, which can limit this process.

Sildenafil works by inhibiting PDE5, thereby preventing the breakdown of cGMP and allowing it to accumulate. This results in prolonged smooth muscle relaxation and enhanced blood flow to the penis, making it easier to achieve and maintain an erection when sexually stimulated. It is important to note that sildenafil does not cause spontaneous erections; sexual arousal is still required for the medication to be effective.

Sildenafil is also licensed for the treatment of pulmonary arterial hypertension at different doses, though this article focuses on its use for erectile dysfunction. Further information on the mechanism and licensing is available from the MHRA/EMC Summary of Product Characteristics (SmPC) and the NHS sildenafil information page.

How Long Does Sildenafil Take to Work and Last?

Understanding the timing of sildenafil's effects is essential for optimal use. After oral administration, sildenafil is absorbed relatively quickly from the gastrointestinal tract. Most men will begin to notice effects within 30 to 60 minutes of taking the tablet, though this can vary between individuals. Peak plasma concentrations are typically reached approximately one hour after ingestion.

According to the MHRA-approved SmPC, sildenafil may be taken approximately 30 minutes to four hours before sexual activity, giving some flexibility in timing. The duration of action is generally around four to five hours. During this window, men may find it easier to achieve and maintain erections when sexually stimulated. However, this does not mean that an erection will last for the entire duration — rather, the medication remains active in the system, facilitating erectile function as needed during sexual activity. After this period, the effects gradually diminish as the drug is metabolised and eliminated from the body, primarily via the liver.

It is important to note that sildenafil does not increase the duration of individual erections beyond what is natural during sexual activity. There is no established link between sildenafil and significantly prolonged erection timing in the sense of extending intercourse duration indefinitely. The medication assists with achieving and maintaining erections but does not directly delay ejaculation or alter sexual stamina. Men seeking help with premature ejaculation may require different treatments and should discuss this with their GP or a specialist.

For best results, sildenafil should be taken on an empty stomach or after a light meal. Heavy, high-fat meals can delay gastric emptying and slow drug absorption, potentially extending the time it takes to work or reducing the magnitude of effect. Grapefruit juice should be avoided around the time of taking sildenafil, as it can inhibit the enzyme CYP3A4 and increase sildenafil plasma levels, raising the risk of side effects. These administration points are detailed in the BNF sildenafil monograph and the MHRA/EMC SmPC.

Factors That Affect Sildenafil's Effectiveness

Several factors can influence how well sildenafil works and how quickly its effects are felt. Understanding these variables can help optimise treatment outcomes and manage expectations appropriately.

Dietary considerations play a significant role. Consuming a large or fatty meal before taking sildenafil can delay gastric emptying and slow drug absorption, resulting in the medication taking longer to work or producing a less pronounced effect. Taking sildenafil on an empty stomach or after a light meal is advisable. As noted above, grapefruit juice should also be avoided.

Alcohol consumption can also affect effectiveness. While moderate alcohol intake is unlikely to cause significant problems, excessive drinking can impair erectile function independently of the medication. Alcohol is a central nervous system depressant that can reduce sexual arousal and make it more difficult to achieve an erection, potentially counteracting sildenafil's benefits.

Underlying health conditions significantly affect response to treatment. Conditions such as diabetes, cardiovascular disease, neurological disorders, and hormonal imbalances can all contribute to erectile dysfunction and may reduce sildenafil's effectiveness. Men with severe vascular disease may have limited blood flow improvements despite PDE5 inhibition. In line with NICE Clinical Knowledge Summary (CKS) guidance on erectile dysfunction, a comprehensive assessment is recommended, including screening for diabetes (HbA1c), dyslipidaemia, and thyroid disease where indicated; measurement of morning total testosterone (repeated if low); urinalysis; and cardiovascular risk assessment using a validated tool such as QRISK. Men at high cardiovascular risk should be referred to cardiology before commencing treatment.

Psychological factors including stress, anxiety, depression, and relationship difficulties can interfere with sexual function. Sildenafil addresses the physiological aspects of ED but cannot resolve psychological barriers. Combined approaches involving counselling or psychosexual therapy may be beneficial, and referral for psychosexual therapy should be considered where significant psychological factors are identified.

Drug interactions must be carefully considered. Certain medications, particularly nitrates (used for angina) and nitric oxide donors (including amyl nitrite, sometimes called 'poppers'), are absolutely contraindicated with sildenafil due to the risk of severe, potentially life-threatening hypotension. Nicorandil, which has nitrate-like properties, is also contraindicated. Riociguat (a guanylate cyclase stimulator) is likewise contraindicated due to the risk of hypotension.

Men taking alpha-blockers (e.g., for benign prostatic hyperplasia or hypertension) should be haemodynamically stable on their alpha-blocker therapy before starting sildenafil; a starting dose of 25 mg is recommended in this situation to reduce the risk of symptomatic hypotension.

Potent CYP3A4 inhibitors can significantly increase sildenafil plasma concentrations. Examples include ritonavir and other HIV protease inhibitors, ketoconazole, itraconazole, erythromycin, and clarithromycin. The BNF and MHRA SmPC advise caution and dose reduction in these circumstances; for example, the maximum recommended dose of sildenafil with ritonavir is 25 mg within a 48-hour period. Other antihypertensives may also interact, and all current medications should be disclosed to the prescribing clinician or pharmacist.

Age and metabolism can influence drug clearance. Older adults (aged 65 and over) may metabolise sildenafil more slowly, and a starting dose of 25 mg is recommended in this group, with dose adjustment based on response and tolerability. Similar caution applies in severe renal or hepatic impairment (see dosage section below).

Referral to urology, endocrinology, or psychosexual services should be considered where there are suspected anatomical causes (e.g., Peyronie's disease), endocrine abnormalities, treatment failure or intolerance, or significant psychogenic factors. Men under 40 with persistent ED should also be considered for specialist referral, as per NICE CKS guidance.

Safe Use of Sildenafil: Dosage and NHS Guidance

As noted above, Viagra Connect 50 mg is available as a Pharmacy (P) medicine from registered pharmacists following an appropriate assessment, for men aged 18 and over. All other sildenafil strengths and formulations remain prescription-only medicines (POM) in the UK, requiring assessment and prescription by a qualified healthcare professional.

The standard starting dose for erectile dysfunction is 50 mg, taken approximately one hour before anticipated sexual activity (or between 30 minutes and four hours beforehand). Depending on efficacy and tolerability, the dose may be increased to 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day.

Dose reductions to 25 mg are recommended in the following groups, in line with BNF and MHRA SmPC guidance:

• Adults aged 65 years and over

• Severe renal impairment (creatinine clearance below 30 mL/min)

• Severe hepatic impairment (Child-Pugh class C)

• Concomitant use of potent CYP3A4 inhibitors (e.g., ritonavir, ketoconazole)

• Concomitant use of alpha-blockers (ensure haemodynamic stability first)

According to NICE CKS guidance on erectile dysfunction, men presenting with ED should receive a comprehensive assessment including:

• Medical history covering cardiovascular risk factors, diabetes, neurological conditions, and hormonal disorders

• Medication review to identify potential drug interactions or contributing medicines

• Lifestyle factors including smoking, alcohol use, and physical activity

• Psychological assessment to identify anxiety, depression, or relationship issues

• Physical examination where clinically indicated

• Investigations including HbA1c, fasting lipids, morning total testosterone (repeated if low), urinalysis, and cardiovascular risk assessment (e.g., QRISK)

Before prescribing or supplying sildenafil, healthcare professionals should ensure there are no contraindications. Absolute contraindications include:

• Concurrent use of nitrates (e.g., glyceryl trinitrate, isosorbide mononitrate) or nitric oxide donors (e.g., amyl nitrite/'poppers') or nicorandil, due to the risk of severe hypotension

• Concurrent use of riociguat (a guanylate cyclase stimulator)

• Recent stroke or myocardial infarction (within the preceding six months) or unstable angina

• Severe hepatic impairment (where sildenafil is contraindicated; caution and dose reduction apply in moderate impairment)

• Hypotension (resting blood pressure below 90/50 mmHg)

• Known hypersensitivity to sildenafil or any excipient

Sildenafil is not recommended in men with retinitis pigmentosa or other hereditary degenerative retinal disorders, due to a small number of reports of visual adverse events; this is a precautionary measure rather than an absolute contraindication.

Common adverse effects include headache, facial flushing, indigestion, nasal congestion, and visual disturbances (such as a blue tinge to vision or increased light sensitivity). These are generally mild and transient. Patients should be advised to seek immediate medical attention if they experience:

• Priapism (a painful erection lasting more than four hours), which requires emergency treatment to prevent permanent damage

• Sudden loss of vision or hearing

• Chest pain during or after sexual activity — if this occurs, patients should not take nitrates and should seek urgent medical care immediately, as the combination can cause a dangerous drop in blood pressure

• Severe allergic reactions (e.g., rash, swelling of the face or throat, difficulty breathing)

NHS prescribing: Generic sildenafil is generally available on the NHS for erectile dysfunction. Local formularies typically recommend sildenafil as the first-line PDE5 inhibitor. Other PDE5 inhibitors (e.g., tadalafil, vardenafil) may be subject to Selected List Scheme (SLS) restrictions and are usually only prescribable on the NHS in specific clinical circumstances. Patients should discuss availability with their GP or prescriber.

Patients should contact their GP or pharmacist if the medication is ineffective after several attempts, if side effects are troublesome, or if there are concerns about underlying health conditions.

Reporting side effects: Patients and healthcare professionals are encouraged to report suspected adverse reactions to sildenafil via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk). This helps the MHRA monitor the safety of medicines in the UK.

This article is for informational purposes only. Always follow the advice of your GP, pharmacist, or other qualified healthcare professional, and refer to the MHRA/EMC SmPC, BNF, NICE CKS guidance on erectile dysfunction, and the NHS sildenafil information page for full prescribing and patient information.

Frequently Asked Questions